FDA Inspection 696888 — Syntho Pharmaceuticals, Inc.

Syntho Pharmaceuticals, Inc. — FEI 3003407422

The FDA completed an inspection of Syntho Pharmaceuticals, Inc. on November 8, 2010 in Farmingdale, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 8, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Farmingdale, NY (United States)